Drug & Alcohol Program
The Omnibus Transportation Employee Testing Act of 1991 mandated the Secretary of Transportation to issue regulations to combat prohibited drug use and alcohol misuse in the transportation industry. For that portion of the transportation industry having to do with the provision of and service to the public of mass transportation, FTA is the agency delegated with the authority and responsibility for issuing these implementing rules. These rules are encompassed in 49 CFR Part 655, Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operations.
- Frequently Asked Questions from FTA Grantees Regarding Coronavirus Disease 2019 (COVID-19)
- USDOT COVID-19 Drug & Alcohol Testing Statement of Enforcement Discretion for Substance Abuse Professionals and Service Agents (4-4-2020)
- USDOT Guidance on Compliance with DOT Drug and Alcohol Testing Regulations (3-23-2020)
- This guidance provides clarity to DOT-regulated employers, employees, and service agents on conducting DOT drug-and-alcohol testing given concerns about the Coronavirus Disease 2019 (COVID-19).
- 2020 Random Drug and Alcohol Testing Rates
- In January 2020, FTA published the Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operations announcing the calendar year 2020 drug and alcohol random testing rates for employers subject to FTA's Drug and Alcohol Program.
- FTA Drug and Alcohol Regulation Updates September 2019
- POSTPONED: 15th Annual FTA Drug and Alcohol Program National Conference
Office of Drug and Alcohol Policy and Compliance Updates
This video describes the effects and consequences of prohibited drug use on personal health, safety, and the work environment, and on the signs and symptoms that may indicate prohibited drug use. This video meets the 60- minute training requirement of section 655.14(b)(1) for covered employees.